75F40118D10053
Indefinite Delivery Contract
Overview
Government Description
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE: DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGICAL PRODUCTS.
Awarding / Funding Agency
NAICS
Pricing
Order Dependent (IDV Only)
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Multiple Award
Who Can Use
Single Agency
Vehicle Ceiling
$75,000,000 (49% Used)
Related Opportunity
Analysis Notes
Place of Performance Largest percentage of work under issued task orders completed at: Bethesda, Maryland 20817 United States.
Recompete The following similar solicitation(s) may continue aspects of this idv: Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics, Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics
Direct Award $10,000.00 was obligated directly to this IDV and does not have an associated task order.
Subcontracting Plan This IDC has an Individual Subcontract Plan. The Department of Health and Human Services has an overall 2023 small business subcontracting goal of 32%
Recompete The following similar solicitation(s) may continue aspects of this idv: Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics, Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics
Direct Award $10,000.00 was obligated directly to this IDV and does not have an associated task order.
Subcontracting Plan This IDC has an Individual Subcontract Plan. The Department of Health and Human Services has an overall 2023 small business subcontracting goal of 32%
International Business Machines Corporation was awarded
Indefinite Delivery Contract 75F40118D10053 (75F401-18-D-10053)
by
the FDA Office of Acquisition and Grant Services
in September 2018.
The IDC
has a duration of 5 years and
was awarded
through solicitation Biologics Effectiveness and Safety (BEST) Initiative: Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Products
full & open
with
NAICS 518210 and
PSC B537
via direct negotiation acquisition procedures with 5 bids received.
To date, $36,934,291 has been obligated through this vehicle.
The total ceiling is $75,000,000, of which 49% has been used.
The vehicle was awarded through Biologics Effectiveness and Safety (BEST) Initiative - New and Innovative Methods for Automated Reporting.
Status
(Complete)
Modified 6/28/23
Period of Performance
9/26/18
Start Date
9/26/23
Ordering Period End Date
Task Order Obligations
$36.9M
Total Obligated
$36.9M
Current Award
$36.9M
Potential Award
Award Hierarchy
Indefinite Delivery Contract
75F40118D10053
Contracts
Subcontracts
Federal Award Analysis
Historical federal task order obligations under 75F40118D10053
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Contract Awards
Prime task orders awarded under 75F40118D10053
Subcontract Awards
Disclosed subcontracts for 75F40118D10053
Opportunity Lifecycle
Procurement history for 75F40118D10053
Transaction History
Modifications to 75F40118D10053
People
Suggested agency contacts for 75F40118D10053
Competition
Number of Bidders
5
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
VV9KH3L99VE3
Awardee CAGE
3BXY7
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Created By
hhswdutter
Last Modified By
hhswdutter
Approved By
hhswdutter
Legislative
Legislative Mandates
Labor Standards
Awardee District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
Jamie Raskin
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) | Consumer and occupational health and safety | Other services from non-Federal sources (25.2) | $32,336,036 | 91% |
| FDA Innovation, CURES Act, Food and Drug Administration, Health and Human Services (075-5629) | Consumer and occupational health and safety | Other services from non-Federal sources (25.2) | $3,392,556 | 9% |
Last Modified: 6/28/23